CLEC9A 产品
(C-Type Lectin Domain Family 9, Member A (CLEC9A))
Categories
CLEC9A is a group V C-type lectin-like receptor (CTLR) that functions as an activation receptor and is expressed on myeloid lineage cells (Huysamen et al., 2008 [PubMed 18408006]).[supplied by OMIM, Aug 2008].
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Featured CLEC9A Categories
CLEC9A 抗体
High quality antibodies with extensive validation data.
CLEC9A ELISA试剂盒
Reliable ELISA kits for a wide range of species.
CLEC9A 蛋白
Proteins for various applications incl. WB, ELISA, IF etc.
Recommended CLEC9A 抗体
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Application
ELISA, FACS
Validations
- (4)
Cat. No.
ABIN7193288
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB
Validations
- (3)
Cat. No.
ABIN950110
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
FACS, ICC
Validations
- (3)
Cat. No.
ABIN7013959
Quantity
0.1 mg
Datasheet
Datasheet
Recommended CLEC9A ELISA试剂盒
Product
Reactivity
Analytical Method
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
Cat. No.
ABIN6973791
Quantity
96 tests
Datasheet
Datasheet
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
Cat. No.
ABIN4882384
Quantity
96 tests
Datasheet
Datasheet
Reactivity
Human
Analytical Method
Semi-Quantitative Sandwich ELISA
Validations
Cat. No.
ABIN6385875
Quantity
96 tests
Datasheet
Datasheet
Recommended CLEC9A 蛋白
Product
Reactivity
Source
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Source
HEK-293 Cells
Validations
- (3)
Cat. No.
ABIN7274357
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Mouse
Source
HEK-293 Cells
Validations
- (2)
Cat. No.
ABIN7274367
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Source
Escherichia coli (E. coli)
Validations
- (1)
Cat. No.
ABIN7122064
Quantity
50 μg
Datasheet
Datasheet
Latest Publications for our CLEC9A Products
: "Defining human dendritic cell progenitors by multiparametric flow cytometry." in: Nature protocols, Vol. 10, Issue 9, pp. 1407-22, (2016) (PubMed).: "Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates." in: European journal of immunology, Vol. 45, Issue 3, pp. 854-64, (2015) (PubMed).
: "Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 193, Issue 4, pp. 1622-35, (2014) (PubMed).
: "TLR3-responsive, XCR1+, CD141(BDCA-3)+/CD8α+-equivalent dendritic cells uncovered in healthy and simian immunodeficiency virus-infected rhesus macaques." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 10, pp. 4697-708, (2014) (PubMed).
: "Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas." in: European journal of immunology, Vol. 44, Issue 7, pp. 1947-55, (2014) (PubMed).
: "Boosting antibody responses by targeting antigens to dendritic cells." in: Trends in immunology, Vol. 33, Issue 2, pp. 71-7, (2012) (PubMed).
: "Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A." in: European journal of immunology, Vol. 40, Issue 5, pp. 1255-65, (2010) (PubMed).
Synonyms and alternative names related to CLEC9A
C-type lectin domain family 9, member a (Clec9a), C-type lectin domain containing 9A (CLEC9A), C-type lectin domain containing 9A (Clec9a), C-type lectin domain family 9, member A (CLEC9A), 9830005G06Rik, DNGR-1, DNGR1, RGD1562513, UNQ9341Protein level used designations for CLEC9A
- C-type lectin domain family 9 member A
- dendritic cell natural killer lectin group receptor 1
- HEEE9341
You are here:
